Related Experiment Video
Updated: Jul 6, 2026

Heterogeneity Mapping of Protein Expression in Tumors using Quantitative Immunofluorescence
Published on: October 25, 2011
Undifferentiated tumor: true identity by immunohistochemistry
Armita Bahrami1, Luan D Truong, Jae Y Ro
1Department of Pathology, Baylor College of Medicine, Houston, TX, USA.
Identifying the origin of undifferentiated tumors is key for effective treatment. Immunohistochemical analysis using broad marker panels helps accurately classify these neoplasms, distinguishing between epithelial, mesenchymal, melanocytic, or hematopoietic origins.
Area of Science:
- Oncology
- Pathology
- Immunohistochemistry
Background:
- Undifferentiated tumors lack clear differentiation markers on standard microscopy.
- Accurate classification is essential for patient treatment and prognosis.
Purpose of the Study:
- To determine the precise nature of undifferentiated tumors using immunohistochemical analysis.
- To establish a systematic approach for diagnosing these challenging neoplasms.
Main Methods:
- Comprehensive literature review.
- Analysis of authors' clinical experience.
- Application of immunohistochemical screening panels.
Main Results:
- Immunohistochemistry is crucial for differentiating epithelial, mesenchymal, melanocytic, and hematopoietic tumors.
- Broad panels including expected positive and negative markers minimize diagnostic errors from aberrant antigen expression.
- Algorithmic analysis aids in categorizing small round cell, carcinomatous, sarcomatous, and overlapping tumors.
Conclusions:
- Accurate lineage determination of undifferentiated tumors is vital for clinical management.
- A systematic immunohistochemical approach is fundamental for accurate diagnosis.
- Understanding marker expression patterns, including aberrant ones, is key to avoiding misinterpretation.
More Related Videos
08:57Identifying, Diagnosing, and Grading Malignant Peripheral Nerve Sheath Tumors in Genetically Engineered Mouse Models
Published on: May 17, 2024
08:32Enrichment and Characterization of the Tumor Immune and Non-immune Microenvironments in Established Subcutaneous Murine Tumors
Published on: June 7, 2018